Management

John Melo has nearly three decades of combined experience as a business leader and expert in the global fuels industry. As President and Chief Executive Officer, Mr. Melo has led Amyris through successful technology development, industrial start up, product development and commercialization and a series of funding rounds, including the initial public offering in the fall of 2010. Before joining Amyris in 2007, Mr. Melo served in various senior management positions at BP Plc (formerly British Petroleum) most recently as President of U.S. fuels operations where he successfully led programs to increase marketing volumes, reduce costs, and significantly improve financial returns. During his tenure at BP, Mr. Melo also served as Chief Information Officer of the refining and marketing segment; Senior Advisor for e-business strategy to Lord Browne, BP group chief executive; and Director of global brand development. In this last role, he helped develop the “Helios” re-branding effort. Before joining BP, Mr. Melo was with Ernst & Young and a member of the management teams for several startup companies, including Computer Aided Services and Alldata Corporation. Mr. Melo currently serves on the board of directors of U.S. Venture, Inc. and Renmatix Inc., serves as Vice Chairman of the Board of Directors of the Bay Area Biosciences Association (BayBio), is a member of the Council for the Portuguese Diaspora and is a member of Young Presidents Organization (YPO). Mr. Melo is an appointed member to the U.S. section of the U.S.-Brazil CEO Forum. When not working on building Amyris or championing the eradication of malaria, John enjoys skiing, reading and time with his family on the Pico Island of the Azores, his childhood home.

Download Photo

Holdings: 305,401 shares     View Transactions
Date	Type	Shares Traded	Price Range
Apr 1, 2013	Disposition (Non Open Market)	6,113	3.06
Jan 2, 2013	Disposition (Non Open Market)	3,364	3.20
Aug 31, 2012	Sell	553,730	3.70
Aug 31, 2012	Sell	115,000	3.70
Aug 31, 2012	Option Execute	553,730	0.28
Aug 31, 2012	Option Execute	115,000	0.28
May 15, 2012	Acquisition (Non Open Market)	3,273	1.53
Apr 9, 2012	Acquisition (Non Open Market)	250,000	n/a
Jan 3, 2012	Disposition (Non Open Market)	3,225	12.27
Oct 10, 2011	Automatic Sell	20,000	17.22
Oct 10, 2011	Option Execute	20,000	0.28
Aug 10, 2011	Automatic Sell	27,500	20.02 - 20.67
Aug 10, 2011	Option Execute	27,500	0.28
Aug 9, 2011	Automatic Sell	23,800	19.66 - 20.44
Aug 9, 2011	Option Execute	23,800	0.28
Aug 8, 2011	Automatic Sell	18,500	20.04 - 20.55
Aug 8, 2011	Option Execute	18,500	0.28
Jul 8, 2011	Automatic Sell	6,000	28.28
Jul 8, 2011	Option Execute	6,000	0.28
Jul 7, 2011	Automatic Sell	7,000	27.97
Jul 7, 2011	Option Execute	7,000	0.28
Jul 6, 2011	Automatic Sell	4,500	28.21
Jul 6, 2011	Option Execute	4,500	0.28
Jul 5, 2011	Automatic Sell	8,000	27.89
Jul 5, 2011	Option Execute	8,000	0.28
Jul 1, 2011	Automatic Sell	19,970	28.05
Jul 1, 2011	Option Execute	19,970	0.28
Jun 30, 2011	Automatic Sell	11,900	28.19
Jun 30, 2011	Option Execute	11,900	0.28
Apr 15, 2011	Acquisition (Non Open Market)	23,000	n/a
Mar 29, 2011	Automatic Sell	53,100	27.99
Mar 29, 2011	Option Execute	53,100	0.28
Mar 28, 2011	Automatic Sell	56,000	27.10
Mar 28, 2011	Option Execute	56,000	0.28

Steven Mills has more than three decades of experience in the fields of accounting, corporate finance, strategic planning and mergers and acquisitions. Prior to joining Amyris in May 2012, he served as Senior Executive Vice President of Performance & Growth at Archer-Daniels-Midland Company (ADM), a global agricultural commodity processing company, from December 2010 to February 2012. Previously, he served as ADM's Executive Vice President and Chief Financial Officer from March 2008 to December 2010. Mr. Mills joined ADM in 1979 and served in various senior accounting and treasury roles, including 12 years as Controller. He has been a director and a member of the audit committee of Black Hills Corporation, a diversified energy holding company, since October 2011. Mr. Mills also serves on the boards of Illinois College and Hickory Point Bank & Trust. He holds a Bachelor of Science degree in Mathematics from Illinois College in Jacksonville, Illinois.

Download Photo

Holdings: 240,830 shares     View Transactions
Date	Type	Shares Traded	Price Range
Apr 1, 2013	Disposition (Non Open Market)	9,170	3.06
May 29, 2012	Acquisition (Non Open Market)	250,000	n/a

Joel Cherry leads Amyris research and development, including various ongoing collaborations. Prior to joining Amyris, Dr. Cherry was Senior Director of bioenergy biotechnology at Novozymes. During his tenure at Novozymes, he was a member of the R&D management team specializing in protein engineering and directed evolution technologies. He was also principal investigator and director of the BioEnergy Project, an effort funded by the U.S. Department of Energy to reduce the cost of enzymes used in converting biomass to sugar. This work was awarded an R&D 100 Award, Scientific American Top 50 Award, and a Frost and Sullivan Emerging Technology Award. Dr. Cherry is an inventor on more than 20 issued patents, author of three book chapters and more than 30 scientific publications, and an invited speaker at numerous international conferences on biofuels. He received his B.A. from Carleton College in chemistry, a Ph. D. in biochemistry from the University of New Hampshire.

Download Photo

Holdings: 158,438 shares     View Transactions
Date	Type	Shares Traded	Price Range
Apr 1, 2013	Disposition (Non Open Market)	6,724	3.06
May 15, 2012	Acquisition (Non Open Market)	1,103	1.53
Apr 9, 2012	Acquisition (Non Open Market)	155,000	n/a
Jan 3, 2012	Disposition (Non Open Market)	1,402	12.27
Jan 3, 2012	Disposition (Non Open Market)	1,462	3.20
Sep 26, 2011	Automatic Sell	4,500	19.47
Sep 26, 2011	Option Execute	4,500	4.31
Aug 29, 2011	Automatic Sell	500	19.89
Aug 29, 2011	Option Execute	500	4.31
Aug 26, 2011	Automatic Sell	4,000	18.35
Aug 26, 2011	Option Execute	4,000	4.31
Aug 8, 2011	Automatic Sell	4,500	20.05
Aug 8, 2011	Option Execute	4,500	4.31
Jun 27, 2011	Automatic Sell	5,000	29.75 - 30.37
Jun 27, 2011	Option Execute	5,000	4.31
Jun 24, 2011	Automatic Sell	4,397	29.90
Jun 24, 2011	Option Execute	4,397	4.31
Jun 21, 2011	Automatic Sell	3,068	29.91
Jun 21, 2011	Option Execute	3,068	4.31
May 27, 2011	Automatic Sell	914	29.90
May 27, 2011	Option Execute	914	4.31
May 26, 2011	Automatic Sell	6,621	28.64 - 29.90
May 26, 2011	Option Execute	6,621	4.31
May 9, 2011	Automatic Sell	5,000	25.01
May 9, 2011	Option Execute	5,000	4.31
Apr 15, 2011	Acquisition (Non Open Market)	10,000	n/a
Mar 29, 2011	Automatic Sell	3,000	28.08
Mar 29, 2011	Option Execute	3,000	4.31
Mar 28, 2011	Automatic Sell	5,000	27.14
Mar 28, 2011	Option Execute	5,000	4.31

Paulo Diniz leads Amyris operations in Brazil. Prior to joining Amyris in March 2011, Mr. Diniz served as Chief Financial Officer of Bunge Brasil S.A., a wholly owned subsidiary of Bunge Ltd., an agribusiness and food company, from April 2009 to November 2010. From 2003 to April 2009, Mr. Diniz was Chief Financial Officer and a member of the board of directors of Cosan S.A., a renewable energy company. He received a Master of Business Administration degree from International Institute for Management Development (IMD) in Switzerland, a B. of Sc. degree in Production Engineering from the University of São Paulo (USP) in Brazil, and did post graduate work in human resources at INSEAD in France.

Download Photo

Holdings: 90,000 shares     View Transactions
Date	Type	Shares Traded	Price Range
Apr 9, 2012	Acquisition (Non Open Market)	50,000	n/a
Apr 15, 2011	Acquisition (Non Open Market)	40,000	n/a

Chuck Kraft leads Amyris global manufacturing and process development operations. Mr. Kraft has three decades of experience in specialty fermentation. Prior to joining Amyris, he was Vice President of Operations, and earlier Vice President of Engineering, at DuPont Tate and Lyle BioProducts, a joint venture producing 1, 3-propanediol (Bio-PDO™) via fermentation of plant-based sugars. Previously, for nearly two decades, he held a number of operational positions at Tate & Lyle's citric acid production facility in the United States. He holds MBA and B.S. Degrees from the University of Dayton, Ohio.

Download Photo

Gary Loeb joined Amyris in 2011 as Senior Corporate and Regulatory Counsel and became General Counsel and Corporate Secretary in May 2012. Previously, Mr. Loeb was Vice President of Intellectual Property at Genentech, Inc., where he most recently served as the senior-most attorney under General Counsel, overseeing a team of more than 90 employees, including 30 attorneys, and serving as Chief Litigation and Intellectual Property Officer among other positions with the company. Prior to joining Genentech in 2000, Mr. Loeb practiced general intellectual property law in Los Angeles and San Francisco. Mr. Loeb holds a J.D. from the Columbia Law School and B.S. on Biological Sciences from Stanford University. Mr. Loeb is also an Adjunct Professor at the University of San Francisco School of Law, where he lectures on biotechnology law.

Download Photo

Holdings: 108,389 shares     View Transactions
Date	Type	Shares Traded	Price Range
Apr 9, 2013	Disposition (Non Open Market)	611	2.90
Oct 31, 2012	Statement of Ownership	0	n/a

Zanna McFerson leads business development, commercial and product line activities.  Prior to joining Amyris, McFerson was Vice President of Cargill and Business Director of Truvia®, the leading global natural sugar substitute business she helped create over the past decade. In this position, she directed an extensive global team with resources across research and development, agronomy, supply chain, scientific and regulatory affairs, sales and marketing.  She has played a leading role in fundamentally changing the sugar substitute industry by creating consumer demand for a novel sweetener and in forming a trade group, The International Stevia Council, where she most recently served as President.  During her tenure, the business received numerous awards in the area of technology, public relations and marketing while lauded for its sustainability efforts.  A native of Finland, McFerson joined Cargill in 1990 as a commodity trader and held various roles in sales, business management, and new product development at Cargill.  She received a bachelor’s degree in Economics from the University of Illinois and a Masters of Business Administration from the University of Iowa.

Download Photo

Jack Newman co-founded Amyris with over a decade of experience researching bacterial physiology and genetics. In addition to publishing in leading molecular biology and biotechnology journals, Dr. Newman co-authored the groundbreaking work underlying the technology of microbial terpene production. Dr. Newman received his doctorate from the University of Wisconsin, Madison, in the field of microbial physiology and gene regulation, and a B.A. in molecular and cellular biology from the University of California, Berkeley.

Download Photo

Christine Ring leads Amyris technology strategy and licensing activities. Dr. Ring has served as our Chief Intellectual Property Counsel since August 2006, and Senior Vice President for Technology Strategy & Licensing since January 2012. Prior to Amyris, she was the Director of Intellectual Property at Sunesis Pharmaceuticals, Inc. and was Senior Patent Attorney at Kosan Biosciences. Before becoming in-house counsel, she began her legal career in private practice, most recently as Senior Attorney at Pillsbury Madison & Sutro (now Pillsbury Winthrop Shaw & Pittman). Chris has a J.D. from Hastings College of the Law, a Ph. D. in Pharmaceutical Chemistry from University of California, San Francisco, and an A.B. in Biophysics from University of California, Berkeley.

Download Photo

Karen Rohde is Amyris's Chief Human Resources Officer. Previously, Ms. Rohde was Senior Vice President Human Resources for Hitachi Global Storage Technologies, Inc. (HGST), where she helped drive the company’s turnaround by building a customer-focused, high-performance culture that promoted global alignment, agility and collaboration across its 45,000 employee organization. Prior to HGST, she was Senior Vice President Human Resources & Chief Talent Officer for Sun Microsystems, Inc.  During her 13-year tenure at Sun, Rohde designed and implemented competitive, integrated talent systems and supported multiple acquisitions.  Rohde began her career in Finance at Mobil Oil Corporation.  Rohde has an MBA from the Haas Business School at University of California at Berkeley and a BA in English from the University of California at Irvine. 

Joel Velasco leads Amyris investor relations, external communications, and public policy. Mr. Velasco joined Amyris in January 2011 from the Brazilian Sugarcane Industry Association (UNICA) where as Chief Representative in North America he led UNICA's efforts to expand international biofuel and sugar markets. Prior to joining UNICA, Velasco was managing director of Albright Stonebridge, an international strategic advisory firm based in Washington, D.C. and previously served as senior advisor to the U.S. Ambassador to Brazil and as a personal aide to Vice President Al Gore in the White House. Mr. Velasco received an M.A. from the Georgetown University School of Foreign Service, focusing his studies on the political-economy of the Southern Cone, and a B.A. in Political Science from Hampden-Sydney College in Virginia.

Download Photo